However, this is similar to another study in which CD133, being more significantly and more frequently expressed in gastric GIST (48%) than in intestinal GIST (4%), was also found to be a significant poor prognostic factor regarding overall survival in GIST[47]. This evidence concerns the gene PROM1 and gastrointestinal stromal tumor.